Cellulite News and Research

RSS
Cellulite describes a condition that is claimed to occur in most women, where the skin of the lower limbs, abdomen, and pelvic region becomes dimpled.
Endo International enters into definitive agreement to acquire Auxilium Pharmaceuticals

Endo International enters into definitive agreement to acquire Auxilium Pharmaceuticals

Cynosure's PicoSure Picosecond Laser Workstation receives FDA clearance for treatment of wrinkles

Cynosure's PicoSure Picosecond Laser Workstation receives FDA clearance for treatment of wrinkles

New Jersey physician offers FDA-approved non-invasive fat reduction treatment

New Jersey physician offers FDA-approved non-invasive fat reduction treatment

Auxilium Pharmaceuticals' CCH drug effective against cellulite in Phase 2a study

Auxilium Pharmaceuticals' CCH drug effective against cellulite in Phase 2a study

BioSpecifics Technologies total revenue for second quarter decreases by 19%

BioSpecifics Technologies total revenue for second quarter decreases by 19%

BioSpecifics Technologies initiates CCH Phase 2 clinical trial in patients with lipoma

BioSpecifics Technologies initiates CCH Phase 2 clinical trial in patients with lipoma

Auxilium Pharmaceuticals' total revenues decrease 17% to $83 million in Q2 2014

Auxilium Pharmaceuticals' total revenues decrease 17% to $83 million in Q2 2014

Syneron Medical to host investor meeting to highlight opportunities in body contouring/fat treatment market

Syneron Medical to host investor meeting to highlight opportunities in body contouring/fat treatment market

Cynosure gets marketing approval from FDA for PicoSure Picosecond Laser Workstation

Cynosure gets marketing approval from FDA for PicoSure Picosecond Laser Workstation

Auxilium Pharmaceuticals plans to merge with QLT

Auxilium Pharmaceuticals plans to merge with QLT

Auxilium and Prasco introduce authorized generic version of Testim

Auxilium and Prasco introduce authorized generic version of Testim

Auxilium Pharmaceuticals presents new XIAFLEX clinical trial data at AUA Meeting

Auxilium Pharmaceuticals presents new XIAFLEX clinical trial data at AUA Meeting

Syneron Candela looks at latest non-invasive body shaping technologies

Syneron Candela looks at latest non-invasive body shaping technologies

Chromogenex launches non-surgical fat reduction and body shaping system

Chromogenex launches non-surgical fat reduction and body shaping system

Syneron's Sublative technology receives CE Mark for effective treatment of striae, acne scars

Syneron's Sublative technology receives CE Mark for effective treatment of striae, acne scars

Auxilium Pharmaceuticals’ net revenues increase $125.9M to 56%

Auxilium Pharmaceuticals’ net revenues increase $125.9M to 56%

Syneron Medical enters into agreement to acquire New Star Lasers

Syneron Medical enters into agreement to acquire New Star Lasers

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.